Connection
Kelly Knupp to Adolescent
This is a "connection" page, showing publications Kelly Knupp has written about Adolescent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.654 |
|
|
|
-
Nabbout R, Devinsky O, Lagae L, Scheffer IE, Guerrini R, Sullivan J, Gil-Nagel A, Zuberi SM, Riney K, Healy P, Abraham J, Roper RZ, Langlois M, Lothe A, Knupp KG. Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study. Epilepsia Open. 2026 Oct; 11(5):1871-1879.
Score: 0.061
-
Knupp KG, Scheffer IE, Schoonjans AS, Sullivan J, Lagae L, Auvin S, Thiele EA, Guerrini R, Zuberi SM, Nabbout R, Riney K, Nickels KC, Davis R, Lock MD, Dai D, Minh T, Zhang Roper R, Dickson N, Langlois M, Lothe A, Gil-Nagel A. Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers. Epilepsy Behav. 2025 Dec; 173:110753.
Score: 0.058
-
Knupp KG, Scheffer IE, Ceulemans B, Sullivan J, Nickels KC, Lagae L, Guerrini R, Zuberi SM, Nabbout R, Riney K, Agarwal A, Lock M, Dai D, Farfel GM, Galer BS, Gammaitoni AR, Polega S, Davis R, Gil-Nagel A. Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia. 2023 01; 64(1):139-151.
Score: 0.047
-
Knupp KG, Scheffer IE, Ceulemans B, Sullivan JE, Nickels KC, Lagae L, Guerrini R, Zuberi SM, Nabbout R, Riney K, Shore S, Agarwal A, Lock M, Farfel GM, Galer BS, Gammaitoni AR, Davis R, Gil-Nagel A. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial. JAMA Neurol. 2022 06 01; 79(6):554-564.
Score: 0.046
-
Knupp KG, Rice JD, Helmkamp LJ, Galinkin J, Sempio C, Jost K, Chapman KE. Prospective evaluation of oral cannabis extracts in children with epilepsy. Seizure. 2019 Nov; 72:23-27.
Score: 0.038
-
Eschbach K, Scarbro S, Juarez-Colunga E, Allen V, Hsu S, Knupp K. Growth and endocrine function in children with Dravet syndrome. Seizure. 2017 Nov; 52:117-122.
Score: 0.033
-
Knupp KG, Scarbro S, Wilkening G, Juarez-Colunga E, Kempe A, Dempsey A. Parental Perception of Comorbidities in Children With Dravet Syndrome. Pediatr Neurol. 2017 Nov; 76:60-65.
Score: 0.032
-
Treat L, Chapman KE, Colborn KL, Knupp KG. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients. Epilepsia. 2017 01; 58(1):123-127.
Score: 0.031
-
Nabbout R, Sullivan J, Auvin S, Cross JH, Devinsky O, Gil-Nagel A, Guerrini R, Knupp KG, Perry MS, Sánchez-Carpintero R, Schoonjans AS, Scheffer IE, Specchio N, Strzelczyk A, Wheless J, Wirrell EC, Morita D, Healy P, Langlois M, Lothe A, Lagae L. Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics. Epilepsia Open. 2026 Oct; 11(5):1692-1705.
Score: 0.015
-
Choudhari PR, Bonds K, Eschbach K, Chapman KE, Alexander A, Knupp KG, Park K, Demarest S, Bird W, Sirsi D, Talai A, Said R, Joshi C. Predicting pediatric epilepsy surgery outcomes via a multidisciplinary epilepsy surgery conference survey. Epilepsy Res. 2026 Nov; 227:107895.
Score: 0.015
-
Gil-Nagel A, Knupp KG, Gunning B, Battaglia DI, Thiele EA, Scheffer IE, Schoonjans AS, Nabbout R, Villeneuve N, Klotz KA, Specchio N, Sanchez-Carpintero R, Zolnowska M, Schulz AL, Perrin L, Dickson N, Langlois M, Lothe A, Sullivan J. Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness. Epilepsia. 2026 Oct; 67(10):5227-5242.
Score: 0.015
-
Rubin DH, Suecoff SA, Knupp KG. Headaches in children. Pediatr Ann. 2006 May; 35(5):345-53.
Score: 0.015
-
Kuperman R, Blanco NJ, Buchhalter J, Kessler S, Knupp K, Lin N, Kremer K, Aungaroon G. Novel Smartphone-Based Screening Tool for Absence Seizures in Pediatric Settings: A Comparative Study With Video EEG. Pediatr Neurol. 2026 Jul; 180:52-58.
Score: 0.015
-
Laux L, Sullivan J, Perry MS, Brunklaus A, Desurkar A, Schreiber JM, Roberts CM, Knupp KG, Wheless JW, Wirrell EC, Ventola P, Wang F, Lynch J, Parkerson KA, Ticho B, Cross JH. Zorevunersen in Children and Adolescents with Dravet Syndrome. N Engl J Med. 2026 Mar 05; 394(10):969-982.
Score: 0.015
-
Sullivan J, Wirrell EC, Knupp KG, Ciliberto M, Ziobro J, Chen DY, Flamini JR, Zafar M, LaVallee N, Stepanians M, Ventola P, Chavan TS, Wang F, Parkerson KA, Ticho B. Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-Up. Neurology. 2025 Dec 09; 105(11):e214388.
Score: 0.014
-
Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien T, Penovich P, French J, Knupp KG, Holmes M, Barnard S, Kanner AM, Meador KJ. Pre-treatment seizures and cognition at the time of focal epilepsy diagnosis. Epilepsy Behav. 2025 Nov; 172:110746.
Score: 0.014
-
Stillman C, Knupp K, Oliver J, Conley A, Kennedy K, Silveira L, Joshi C. A retrospective analysis of pediatric patients on a ketogenic diet: A comparison of inpatient versus outpatient diet initiations. Epilepsy Res. 2025 08; 214:107556.
Score: 0.014
-
Condon C, Parkerson KA, Dandurand A, Wang F, Howse C, Mayhew M, Whyman S, Ventola P, Anne Meskis M, Sullivan J, Knupp KG, Gater A, Mahon-Smith A. Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: Caregiver and clinician perspectives. Epilepsy Behav. 2025 06; 167:110381.
Score: 0.014
-
Figueroa AG, Fulton RE, Banerji R, Knupp KG, Patel MN. Mitochondrial respiration defects in lymphoblast cell lines from patients with Dravet syndrome. Epilepsia. 2025 Jul; 66(7):2507-2520.
Score: 0.014
-
Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien TJ, Penovich P, French J, Knupp KG, Barnard S, Holmes M, Hegde M, Kanner AM, Meador KJ. Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistance. Epilepsy Behav. 2025 Mar; 164:110293.
Score: 0.014
-
Eschbach K, Reedy J, Gofton T, Gopaul M, Farias-Moeller R, Kellogg M, Knupp K, Hirsch LJ, Wong N, Dorsey Holliman B. Navigating life after New-onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES): Insights from caregiver and patient interviews. Epilepsy Behav. 2025 02; 163:110236.
Score: 0.014
-
Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien TJ, Penovich P, French J, Knupp KG, Meador KJ. Engagement in online cognitive testing with the Cogstate brief battery among a multinational cohort of people with focal epilepsy. Epilepsy Behav. 2024 Oct; 159:109953.
Score: 0.013
-
Sullivan J, Lagae L, Cross JH, Devinsky O, Guerrini R, Knupp KG, Laux L, Nikanorova M, Polster T, Talwar D, Ceulemans B, Nabbout R, Farfel GM, Galer BS, Gammaitoni AR, Lock M, Agarwal A, Scheffer IE. Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial. Epilepsia. 2023 10; 64(10):2653-2666.
Score: 0.012
-
Sullivan J, Wirrell E, Knupp KG, Chen D, Zafar M, Flamini R, Stutely J, Brathwaite C, Ventola P, Avendaño J, Parkerson KA, Wyant N, Ticho B. Interim results of adaptive functioning and neurodevelopment in BUTTERFLY - An observational study of children and adolescents with Dravet syndrome. Epilepsy Behav. 2022 12; 137(Pt A):108955.
Score: 0.012
-
Berg AT, Gaebler-Spira D, Wilkening G, Zelko F, Knupp K, Dixon-Salazar T, Villas N, Meskis MA, Harwell V, Thompson T, Sims S, Nesbitt G. Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework. Epilepsy Behav. 2020 10; 111:107287.
Score: 0.010
-
Nabbout R, Mistry A, Zuberi S, Villeneuve N, Gil-Nagel A, Sanchez-Carpintero R, Stephani U, Laux L, Wirrell E, Knupp K, Chiron C, Farfel G, Galer BS, Morrison G, Lock M, Agarwal A, Auvin S. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial. JAMA Neurol. 2020 03 01; 77(3):300-308.
Score: 0.010
-
Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, Devinsky O, Cross JH, Guerrini R, Talwar D, Miller I, Farfel G, Galer BS, Gammaitoni A, Mistry A, Morrison G, Lock M, Agarwal A, Lai WW, Ceulemans B. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2019 12 21; 394(10216):2243-2254.
Score: 0.010
-
Tolete P, Knupp K, Karlovich M, DeCarlo E, Bluvstein J, Conway E, Friedman D, Dugan P, Devinsky O. Lorcaserin therapy for severe epilepsy of childhood onset: A case series. Neurology. 2018 10 30; 91(18):837-839.
Score: 0.009
-
Whittington MD, Knupp KG, Vanderveen G, Kim C, Gammaitoni A, Campbell JD. The direct and indirect costs of Dravet Syndrome. Epilepsy Behav. 2018 03; 80:109-113.
Score: 0.008
-
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR, Gaillard WD, Kossoff EH, Valencia I, Knupp KG, Wusthoff C, Keator C, Dobyns WB, Ryan N, Loddenkemper T, Chu CJ, Novotny EJ, Koh S. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017 09 01; 171(9):863-871.
Score: 0.008
-
Griffin A, Hamling KR, Knupp K, Hong S, Lee LP, Baraban SC. Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome. Brain. 2017 03 01; 140(3):669-683.
Score: 0.008
-
Press CA, Knupp KG, Chapman KE. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav. 2015 Apr; 45:49-52.
Score: 0.007
-
Barberio M, Reiter PD, Kaufman J, Knupp K, Dobyns EL. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012 Jun; 27(6):721-6.
Score: 0.006
-
Reiter PD, Huff AD, Knupp KG, Valuck RJ. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010 Aug; 43(2):117-21.
Score: 0.005
-
Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC. Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol. 2004 Jan; 19(1):59-62.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|